1.05
Nuwellis Inc stock is traded at $1.05, with a volume of 111.54K.
It is up +5.37% in the last 24 hours and down -8.30% over the past month.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
See More
Previous Close:
$0.9965
Open:
$0.9999
24h Volume:
111.54K
Relative Volume:
1.88
Market Cap:
$2.81M
Revenue:
$8.27M
Net Income/Loss:
$-17.52M
P/E Ratio:
-0.0168
EPS:
-62.6089
Net Cash Flow:
$-10.90M
1W Performance:
+5.53%
1M Performance:
-8.30%
6M Performance:
-48.78%
1Y Performance:
+14.50%
Nuwellis Inc Stock (NUWE) Company Profile
Name
Nuwellis Inc
Sector
Industry
Phone
952-345-4200
Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
NUWE
Nuwellis Inc
|
1.05 | 2.67M | 8.27M | -17.52M | -10.90M | -62.61 |
|
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | ROTH MKM | Buy |
Nuwellis Inc Stock (NUWE) Latest News
Nuwellis Q1 2026 Earnings: Significant EPS Miss Despite Stock GainCommunity Hot Stocks - Newser
Nuwellis Inc. (NUWE) Pushes Past Key Support, Tests Resistance at $1.10Momentum ETF - Newser
Nuwellis Offering Up to 4.85M Shrs, 4.85M Series C Warrants and 4.85M Series D Warrants - Moomoo
Nuwellis (NASDAQ: NUWE) files S-1 for warrant-heavy equity raise - Stock Titan
NUWE Technical Analysis | Trend, Signals & Chart Patterns | NUWELLIS INC (NASDAQ:NUWE) - ChartMill
Nuwellis Q3 Earnings Preview - MSN
Nuwellis (NUWE) Stock Analysis: Climbs +1.19%, Eyes on $1.04 2026-05-20Leveraged ETF Flow - Newser
Nuwellis Q1 earnings preview - MSN
Nuwellis (NASDAQ: NUWE) Q1 2026: 26% sales growth but going-concern risk - Stock Titan
Armistice Capital (NUWE) reports 1.06M shares, 7.11% ownership - Stock Titan
Nuwellis (NUWE) Q4 2025 Earnings: EPS $-1.50 Beats EstimatesTangible Book Value - Newser
Q1 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Nuwellis (NUWE) Advances Pediatric Indication for Aquadex SmartF - GuruFocus
Nuwellis receives FDA feedback on pediatric label expansion By Investing.com - Investing.com South Africa
Nuwellis receives FDA feedback on pediatric label expansion - Investing.com
Nuwellis Announces Successful Completion Of FDA Pre-Submission 510(k) Meeting To Expand Aquadex Label - TradingView
Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label - The Manila Times
Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating - Moomoo
Nuwellis moves to let its fluid-removal system treat 5 kg kids - Stock Titan
Nuwellis (NUWE) Gains +5.63% — Support Holds at $1.04 2026-05-14Capital Preservation - Newser
Nuwellis Earnings Call Balances Growth With Cash Strain - The Globe and Mail
Nuwellis Q1 2026 Earnings Call Transcript - Sahm
Nuwellis Inc (NUWE) Q1 2026 Earnings Call Highlights: Strong Rev - GuruFocus
Earnings call transcript: Nuwellis Q1 2026 shows strong revenue growth - Investing.com India
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Nuwellis (Nasdaq: NUWE) grows Q1 2026 sales 26% but posts $4.3M loss - Stock Titan
Nuwellis Q1 2026 Loss Deepens: -$2.09/Share vs -$1.00 Expected - AlphaStreet
Nuwellis Releases Q1 2026 Financial Results - AlphaStreet
TradingKey - TradingKey
Nuwellis, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Nuwellis Q1 2026 Deep Dive: EPS Misses by 109.0%, Revenue Up 26% - AlphaStreet
Nuwellis Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Nuwellis Q1 2026 shows strong revenue growth By Investing.com - Investing.com Nigeria
MSN Money - MSN
Nuwellis (NUWE) Q1 2026 Earnings Transcript - AOL.com
Nuwellis Shifts to Strategic Execution Following First Quarter Results - HarianBasis.co
NUWE: Revenue up 26% year-over-year, with pediatrics driving growth and gross margin at 70.1% - TradingView
NUWE: Revenue up 26% in Q1 2026, with strong pediatric growth and new kidney monitoring acquisition - TradingView
Transcript : Nuwellis, Inc., Q1 2026 Earnings Call, May 12, 2026 - marketscreener.com
Nuwellis, Inc. Reports First Quarter 2026 Financial Results and Strategic Progress - Quiver Quantitative
Nuwellis, Inc. Announces First Quarter 2026 Financial Results - The Manila Times
Nuwellis grows Q1 sales 26% and adds kidney-monitoring tech - Stock Titan
The opportunity most miss about Nuwellis (NUWE) (Technical Weakness) 2026-05-11AI Powered Stock Picks - newser.com
Nuwellis Inc Stock (NUWE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):